4554
Fuji Pharmaceutical Industrial Co., Ltd.
2026/02/05
For Q1 FY2026 ending September, net sales were JPY 15,897 million (22.3% YoY increase), operating income was JPY 2,786 million (122.4% YoY increase), and net income attributable to owners of parent was JPY 324 million (67.2% YoY decrease).
